Board logo

subject: Global Hiv Market: An Analysis - Market Research Reports On Aarkstore Enterprise [print this page]


HIV is a lentivirus and attacks immune system which leads to death. The continuous research has developed treatment for HIV which has made a separate market for HIV drugs. The HIV drug market is increasing due to increasing awareness and diagnosis rates. There are around five million people in low and middle income countries who do not have access to AIDS drugs. HIV is very common in Southern African region. Botswana and Zimbabwe are the most affected countries; HIV is the most underlying reason for more than one third of all deaths among children under age of five.

In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment.

The report outlines major countries affected from HIV virus and death rates. It also gives an overview of HIV virus and therapies in demand. The report presents overview of global market, HIV in US, UK, Asia and Sub-Saharan Africa. It highlights major markets for HIV drugs with overall market value and major drugs revenue.

The report discusses the opportunities prevailing in the HIV drugs market and issues affecting the growth. It also talks about competition prevalent in the market. It profiles major players with an overview of their business, key financials and business strategies.

Table of Contents :

1. Industry Overview

1.1 Introduction

1.2 Treatment for HIV

2. Market Size

2.1 Global HIV Market

HIV/AIDS Cases

2.2 United States

HIV/AIDS Cases by Region

AIDS Diagnoses

2.3 Sub-Saharan Africa

2.4 United Kingdom

Diagnosed Cases

HIV Infected Persons by Region

2.5 Asia

3. HIV Drugs Market

Market Value

Drug Revenue Comparison

4. Market Trends

4.1 Opportunities in HIV Drug Market

Opportunities in Japan

Increasing Number of Cases Leads to Increase in Drug Demand

Increasing Demand of Sexual Health Services

4.2 Key Issues

Policy & Programme Development

Capacity of Communities

Raising Awareness

Gender Issues

5. Major Market Players

5.1 Competition

Major Players Growth Comparison

5.2 Company Profiles

5.2.1 Gilead Science

Overview

Business Strategies

Maintaining Leadership in HIV/AIDS Treatment

Expanded Product Portfolio

Strategic Partnerships

5.2.2 Idenix Pharmaceuticals

Overview

Business Strategies

Restructuring Program

Strong Patent Portfolio

5.2.3 Bristol Myers Squibb

Overview

Business Strategies

Productivity Transformation Initiative

6. Market Forecast

People Receiving Therapy Projections

List of Tables

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Protease Inhibitors (PIs)

HIV/AIDS Worldwide Cases/Deaths (2007)

US AIDS Diagnosis (2006)

Transmission Category of HIV (2006)

Sub-Saharan Africa Cases/Deaths (2007)

HIV/AIDS Diagnosed Cases in UK by Gender (2000-08)

HIV/AIDS Diagnosed Cases in UK by Region (2000-08)

China AIDS Statistics (2007)

Major Players Growth Comparison (2007)

Gilead Revenue by Geography (2005-07)

Idenix Revenue by Products (2006-07)

Bristol-Myers Squibb Revenue by Business Segments (2005-07)

First-line Therapy Projections (2008-13E)

People Receiving Antiretroviral Therapy (2006-08E)

List of Charts

Worldwide HIV/AIDS Cases (2006)

Children Living with HIV Globally (2007)

Top Ten Reported AIDS Cases in US by Region (2006)

HIV Prevalence in Pakistan by Region (2007)

Global HIV Drugs Market (2004-07)

Global HIV Drugs Revenue Comparison (2006)

Global HIV Drugs Revenue Comparison (2007)

Ranking of Americas Largest Pharma Corporations (2007)

Top Biotechnology Companies (2006)

For more information please visit :

http://www.aarkstore.com/reports/Global-HIV-Market-An-Analysis-6801.html

by: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)